Long COVID 4-Year Follow-Up Study
Part of Infections, Lungs & breathing clinical trials.
This study follows up with people who already took part in the BioICOPER study to see how long COVID symptoms and health evolve over 4 years. If you were in that earlier study, you may join this one to help researchers learn more about long-term recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You had a confirmed COVID-19 infection (like a positive test).
- You have been diagnosed with long COVID (symptoms lasting more than 12 weeks).
- You took part in the earlier BioICOPER study.
- You are willing and able to give written permission (informed consent) for this follow-up.
- You do not have a serious illness right now that would make it hard to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people recover from COVID-19 over time, including those with ongoing symptoms (Long COVID). It involves phone interviews and possibly in-person evaluations to understand long-term effects.
This study looks at how COVID-19 can affect health and quality of life over the long term. It may help researchers understand symptoms that can last and what changes people experience after recovery.
This study follows adults who had COVID-19 to learn how the illness can affect health over the long term. It may help researchers understand lasting symptoms and who is at higher risk, which could improve future care.
This study looks at the long-term health effects of COVID-19 in adults. It aims to understand why some people continue to have symptoms and how to better support them.
This study looks at people who have recovered from COVID-19 but still deal with long-term problems. It aims to better understand (and potentially help with) ongoing issues that can affect hormones, metabolism, mood, muscles, the heart, lungs, and skin.
This study builds a health registry to learn how long COVID affects children, teens, and adults over time. It may help by improving understanding of symptoms and care, even if it does not test a new drug.
Hear when a new Persistent COVID Condition trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.